What’s up with PJT’s stock price?
Since the market downfall, PJT’s share price has remained relatively flat. All other public EB’s have nosedived.
Trending Content - Investment Banking Forum
| +156 | Think Twice before Recruiting for HOUSTON IB!! | 65 | 2d |
| +152 | Investment Banks Ranked By Your Divorced Blue Collared Uncle | 15 | 13h |
| +132 | UBS Exits 2026 | 37 | 4h |
| +57 | Congrats on the ROs. I Still Don’t Know Which One You Were | 8 | 2h |
| +40 | Mid-Level UBS Departure for another BB (Grass Isn’t Greener…) | 31 | 3d |
| +37 | IB RO Discussion | 6 | 3d |
| +36 | Did not get a return offer due to headcount, but happy to move on. | 8 | 13h |
| +32 | GS - Low Bonus | 23 | 19h |
| +28 | Early VP promo timeline | 15 | 1d |
| +28 | Lied about bonus to future employer | 16 | 1h |
Career Resources
RSSG is probably going to town, so it makes up for lower M&A revenue
Haha completely forgot about RX. Although, brings up the point that every EB also has a decent RX biz.
HL is the only firm that breaks Rx out in financials. If you look at MD count, would say only HL and PJT are truly restructuring focused enough to be net well positioned in this environment. Rest of the EBs have too much M&A
Would expect rx comprises a larger share of PJT’s business than it does at most other boutiques
Fee backlog + counter cyclical RX business
Doloribus aliquid non ut non qui commodi earum. Maxime soluta repellat odio dolorem. Aut enim tempora inventore. Esse natus deleniti vero et enim veritatis dolor natus. Asperiores incidunt voluptas voluptas. Quibusdam eum et aut.
Earum ab eius et est voluptatem ipsa qui. Tempore cupiditate occaecati reiciendis sint. Id eos blanditiis nihil possimus. Consequuntur explicabo perferendis minima voluptas quae id voluptatem. Perferendis dolores praesentium quia ex.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...